FDA NDC Directory · JSON-LD · Markdown

ARANESP

NDC 55513-005 · HUMAN PRESCRIPTION DRUG · SOLUTION

Generic namedarbepoetin alfa
Labeler / ManufacturerAmgen, Inc
Marketing categoryBiologic License Application · App BLA103951
Dosage form / routeSOLUTION · INTRAVENOUS SUBCUTANEOUS
Active ingredientsDARBEPOETIN ALFA (100 ug/mL)
Marketing started20060911
Package count1

External sources

Source: openFDA. Public-domain (CC0).